Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Riekeld J. Scheper
Treatment With Tumour Infiltrating Lymphocytes and Interleukin-2 in Patients With Metastatic Melanoma: A Pilot Study
Biotherapy
Related publications
Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Biochemotherapy of Metastatic Malignant Melanoma. Predictive Value of Tumour-Infiltrating Lymphocytes
British Journal of Cancer
Cancer Research
Oncology
Neoepitope Targets of Tumour-Infiltrating Lymphocytes From Patients With Pancreatic Cancer
British Journal of Cancer
Cancer Research
Oncology
Tumour Infiltrating Lymphocytes Correlate With Improved Survival in Patients With Esophageal Squamous Cell Carcinoma
Scientific Reports
Multidisciplinary
Minimally Invasive Liver Resection to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy in Patients With Metastatic Melanoma
World Journal of Surgical Oncology
Surgery
Oncology
Tumor-Infiltrating Lymphocytes in Melanoma
Current Oncology Reports
Oncology
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
